May 2003
Volume 44, Issue 13
ARVO Annual Meeting Abstract  |   May 2003
A Study of Ethambutol Neuroretinopathy
Author Affiliations & Notes
  • S. Vistamehr
    Ophthalmology and Visual Sciences, Yale School of Medicine, New Haven, CT, United States
  • R.A. Adelman
    Ophthalmology and Visual Sciences, Yale School of Medicine, New Haven, CT, United States
  • Footnotes
    Commercial Relationships  S. Vistamehr, None; R.A. Adelman, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 4950. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. Vistamehr, R.A. Adelman; A Study of Ethambutol Neuroretinopathy . Invest. Ophthalmol. Vis. Sci. 2003;44(13):4950.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: To study the clinical and electrophysiological findings of ethambutol retinal toxicity. Methods: Retrospective study of our findings and meta-analysis of previous studies of ethambutol toxicity with retinal involvement. Results: Clinical findings of 65 eyes with ethambutol toxicity were reviewed. Fundus abnormalities include retinal hemorrhages in 7 eyes, retinal pigmentary changes in 4 eyes, macular edema in 2 eyes, papillary hyperemia in 14 eyes and optic disc atrophy in 6 eyes. Electrophysiological studies of 114 eyes with ethambutol toxicity showed abnormal ERG in 64 eyes and abnormal EOG in 13 eyes. Conclusions: High dose ethambutol may cause retinal toxicity in addition to the well-known toxic optic neuropathy. Ethambutol retinal toxicity may present with retinal hemorrhage, pigmentary changes and abnormal ERG and EOG. Electrophysiologic tests may be abnormal despite a normal fundus examination. These clinical and electrophysiological evidence are suggestive of ethambutol ocular toxicity being a neuroretinopathy.

Keywords: retina • neuro-ophthalmology: optic nerve 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.